BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31978067)

  • 1. Restoration of Mal overcomes the defects of apoptosis in lung cancer cells.
    Yang LT; Ma F; Zeng HT; Zhao M; Zeng XH; Liu ZQ; Yang PC
    PLoS One; 2020; 15(1):e0227634. PubMed ID: 31978067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-essential role for TLR2 and its signaling adaptor Mal/TIRAP in preserving normal lung architecture in mice.
    Ruwanpura SM; McLeod L; Lilja AR; Brooks G; Dousha LF; Seow HJ; Bozinovski S; Vlahos R; Hertzog PJ; Anderson GP; Jenkins BJ
    PLoS One; 2013; 8(10):e78095. PubMed ID: 24205107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C; Albers A; Amoscato AA; Lotze MT; Wong MK
    Int J Cancer; 2002 Feb; 97(4):458-65. PubMed ID: 11802207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mal-deficiency impairs the tolerogenicity of dendritic cell of patients with allergic rhinitis.
    Shao JB; Yang G; Zhang YY; Ma F; Luo XQ; Mo LH; Liu ZQ; Liao WJ; Qiu QH; Li DC; Yang LT; Zhang XW; Liu DB; Yang PC
    Cell Immunol; 2019 Oct; 344():103930. PubMed ID: 31196568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas and Fas-ligand expression in human pancreatic cancer.
    Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
    Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
    Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
    Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
    Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
    Martin JH; Potthoff A; Ledig S; Cornberg M; Jandl O; Manns MP; Kubicka S; Flemming P; Athmann C; Beil W; Wagner S
    Helicobacter; 2004 Oct; 9(5):371-86. PubMed ID: 15361075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
    Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
    J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells.
    De Paepe ME; Mao Q; Chao Y; Powell JL; Rubin LP; Sharma S
    Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L647-59. PubMed ID: 16148053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli.
    Lorz C; Ortiz A; Justo P; González-Cuadrado S; Duque N; Gómez-Guerrero C; Egido J
    J Am Soc Nephrol; 2000 Jul; 11(7):1266-1277. PubMed ID: 10864583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression.
    Wang H; Zhang X; Sun W; Hu X; Li X; Fu S; Liu C
    Biochem Biophys Res Commun; 2016 Apr; 473(2):377-81. PubMed ID: 26921445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-like Receptor Agonist and Radiation.
    Sato Y; Yoshino H; Tsuruga E; Kashiwakura I
    Curr Cancer Drug Targets; 2020; 20(5):372-381. PubMed ID: 31951181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
    Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
    Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
    J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.
    Syed V; Ho SM
    Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.